Grainyhead-like 2 promotes tumor growth and is associated with poor prognosis in colorectal cancer

Journal of Cancer

Volumn 6, Issue 4, 2015, Pages 342-350

  Quan, Yingjun ^a   Xu, Ming ^a   Cui, Peng ^a   Ye, Min ^a   Zhuang, Biao ^a   Min, Zhijun ^a  

^a FUDAN UNIVERSITY PUDONG MEDICAL CENTER   (China)

Author keywords

Cell cycle; Colorectal cancer; GRHL2; Prognosis; Proliferation

Indexed keywords

CYCLIN A; CYCLIN D1; GRAINYHEAD LIKE 2 PROTEIN; PROTEIN; PROTEIN P21; PROTEIN P27; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CELL CYCLE REGULATION; CELL GROWTH; CELL PROLIFERATION; COHORT ANALYSIS; COLON CARCINOGENESIS; COLON MUCOSA; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HT 29 CELL LINE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; SW620 CELL LINE; TUMOR DIFFERENTIATION; UPREGULATION; WESTERN BLOTTING;

EID: 84923818470     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.10969     Document Type: Article

References (32)

1. Siegel R, Desantis C, Jemal A: Colorectal cancer statistics, 2014. CA: a cancer journal for clinicians 2014, 64(2):104-117.
2. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990, 61(5):759-767.
3. Wilanowski T, Tuckfield A, Cerruti L, O'Connell S, Saint R, Parekh V, Tao J, Cunningham JM, Jane SM: A highly conserved novel family of mammalian developmental transcription factors related to Drosophila grainyhead. Mechanisms of development 2002, 114(1-2):37-50.
4. Auden A, Caddy J, Wilanowski T, Ting SB, Cunningham JM, Jane SM: Spatial and temporal expression of the Grainyhead-like transcription factor family during murine development. Gene expression patterns: GEP 2006, 6(8):964-970.
5. Narasimha M, Uv A, Krejci A, Brown NH, Bray SJ: Grainy head promotes expression of septate junction proteins and influences epithelial morphogenesis. Journal of cell science 2008, 121(Pt 6):747-752.
6. Ting SB, Wilanowski T, Cerruti L, Zhao LL, Cunningham JM, Jane SM: The identification and characterization of human Sister-of-Mammalian Grainyhead (SOM) expands the grainyhead-like family of developmental transcription factors. The Biochemical journal 2003, 370(Pt 3):953-962.
7. Pyrgaki C, Liu A, Niswander L: Grainyhead-like 2 regulates neural tube closure and adhesion molecule expression during neural fold fusion. Developmental biology 2011, 353(1):38-49.
8. Boglev Y, Wilanowski T, Caddy J, Parekh V, Auden A, Darido C, Hislop NR, Cangkrama M, Ting SB, Jane SM: The unique and cooperative roles of the Grainy head-like transcription factors in epidermal development reflect unexpected target gene specificity. Developmental biology 2011, 349(2):512-522.
9. Werth M, Walentin K, Aue A, Schonheit J, Wuebken A, Pode-Shakked N, Vilianovitch L, Erdmann B, Dekel B, Bader M et al: The transcription factor grainyhead-like 2 regulates the molecular composition of the epithelial apical junctional complex. Development 2010, 137(22):3835-3845.
10. Senga K, Mostov KE, Mitaka T, Miyajima A, Tanimizu N: Grainyhead-like 2 regulates epithelial morphogenesis by establishing functional tight junctions through the organization of a molecular network among claudin3, claudin4, and Rab25. Molecular biology of the cell 2012, 23(15):2845-2855.
11. Gao X, Vockley CM, Pauli F, Newberry KM, Xue Y, Randell SH, Reddy TE, Hogan BL: Evidence for multiple roles for grainyheadlike 2 in the establishment and maintenance of human mucociliary airway epithelium. Proceedings of the National Academy of Sciences of the United States of America 2013, 110(23):9356-9361.
12. Varma S, Cao Y, Tagne JB, Lakshminarayanan M, Li J, Friedman TB, Morell RJ, Warburton D, Kotton DN, Ramirez MI: The transcription factors Grainyhead-like 2 and NK2-homeobox 1 form a regulatory loop that coordinates lung epithelial cell morphogenesis and differentiation. The Journal of biological chemistry 2012, 287(44):37282-37295.
13. Tanaka Y, Kanai F, Tada M, Tateishi R, Sanada M, Nannya Y, Ohta M, Asaoka Y, Seto M, Shiina S et al: Gain of GRHL2 is associated with early recurrence of hepatocellular carcinoma. Journal of hepatology 2008, 49(5):746-757.
14. Kang X, Chen W, Kim RH, Kang MK, Park NH: Regulation of the hTERT promoter activity by MSH2, the hnRNPs K and D, and GRHL2 in human oral squamous cell carcinoma cells. Oncogene 2009, 28(4):565-574.
15. Cheng L, Wang P, Yang S, Yang Y, Zhang Q, Zhang W, Xiao H, Gao H, Zhang Q: Identification of genes with a correlation between copy number and expression in gastric cancer. BMC medical genomics 2012, 5:14.
16. Xiang X, Deng Z, Zhuang X, Ju S, Mu J, Jiang H, Zhang L, Yan J, Miller D, Zhang HG: Correction: grhl2 determines the epithelial phenotype of breast cancers and promotes tumor progression. PloS one 2013, 8(4).
17. Yang X, Vasudevan P, Parekh V, Penev A, Cunningham JM: Bridging cancer biology with the clinic: relative expression of a GRHL2-mediated gene-set pair predicts breast cancer metastasis. PloS one 2013, 8(2):e56195.
18. Xiang J, Fu X, Ran W, Chen X, Hang Z, Mao H, Wang Z: Expression and role of grainyhead-like 2 in gastric cancer. Medical oncology 2013, 30(4):714.
19. Cieply B, Riley Pt, Pifer PM, Widmeyer J, Addison JB, Ivanov AV, Denvir J, Frisch SM: Suppression of the epithelial-mesenchymal transition by Grainyhead-like-2. Cancer research 2012, 72(9):2440-2453.
20. Darido C, Georgy SR, Wilanowski T, Dworkin S, Auden A, Zhao Q, Rank G, Srivastava S, Finlay MJ, Papenfuss AT et al: Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis. Cancer cell 2011, 20(5):635-648.
21. Bhandari A, Gordon W, Dizon D, Hopkin AS, Gordon E, Yu Z, Andersen B: The Grainyhead transcription factor Grhl3/Get1 suppresses miR-21 expression and tumorigenesis in skin: modulation of the miR-21 target MSH2 by RNA-binding protein DND1. Oncogene 2013, 32(12):1497-1507.
22. Quan Y, Jin R, Huang A, Zhao H, Feng B, Zang L, Zheng M: Downregulation of GRHL2 inhibits the proliferation of colorectal cancer cells by targeting ZEB1. Cancer biology & therapy 2014, 15(7):878-887.
23. Edge SB, Compton CC: The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Annals of surgical oncology 2010, 17(6):1471-1474.
24. Yu W, Li Q, Yao Y, Quan Y, Zhang Y: Two Novel 30K Proteins Overexpressed in Baculovirus System and Their Antiapoptotic Effect in Insect and Mammalian Cells. International journal of genomics 2013, 2013:323592.
25. Kovacevic Z, Fu D, Richardson DR: The iron-regulated metastasis suppressor, Ndrg-1: identification of novel molecular targets. Biochimica et biophysica acta 2008, 1783(10):1981-1992.
26. Jacob D, Davis J, Fang B: Xenograftic tumor models in mice for cancer research, a technical review. Gene Ther Mol Biol 2004, 8:213-219.
27. Colussi D, Brandi G, Bazzoli F, Ricciardiello L: Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention. International journal of molecular sciences 2013, 14(8):16365-16385.
28. Werner S, Frey S, Riethdorf S, Schulze C, Alawi M, Kling L, Vafaizadeh V, Sauter G, Terracciano L, Schumacher U et al: Dual roles of the transcription factor grainyhead-like 2 (GRHL2) in breast cancer. The Journal of biological chemistry 2013, 288(32):22993-23008.
29. Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. Cell 2011, 144(5):646-674.
30. Duronio RJ, Xiong Y: Signaling pathways that control cell proliferation. Cold Spring Harbor perspectives in biology 2013, 5(3):a008904.
31. Alkarain A, Slingerland J: Deregulation of p27 by oncogenic signaling and its prognostic significance in breast cancer. Breast cancer research: BCR 2004, 6(1):13-21.
32. Starmans MH, Krishnapuram B, Steck H, Horlings H, Nuyten DS, van de Vijver MJ, Seigneuric R, Buffa FM, Harris AL, Wouters BG et al: Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types. British journal of cancer 2008, 99(11):1884-1890.